AI, Embryo Screening, And The Future Of IVF In India
The article explores how Artificial Intelligence is transforming reproductive medicine in India by enhancing embryo and sperm selection processes. It emphasizes that AI acts as a supportive tool for embryologists rather than a replacement, aiming to improve consistency and patient outcomes in IVF treatments.
Why it matters
As infertility rates rise, the integration of AI into reproductive healthcare could significantly improve success rates and accessibility for millions of couples.
Reproductive Medicine has transformed at a much faster pace. During the last four decades, the ART field has moved to more precise, personalised and evidence-based treatments. The patient safety and patient care have also improved in the last decade. The Assisted Reproductive Technology (ART) Act, 2021 of India also has brought in the much-needed regulations which focusses on transparency in the ecosystem for patients and donors. Artificial Intelligence technologies, advanced embryo evaluation and genetics are making their way into this change and India is poised to influence the future of reproductive medicine. Studies report that at least 1 in 6 couples in India experience infertility. Social and demographic tendencies also play a role in changing the composition of patients in fertility centres in metros and tier 2 regions.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in